| 저자 |
Chan Ho Kim1, Mi Jung Lee1, Hyang Mo Koo1, Fa Mee Doh1, Hyung Jung Oh1,Jung Tak Park1, Seung Hyeok Han1, Tae-Hyun Yoo1, Yong-Lim Kim2,Yon Su Kim3, Chul Woo Yang4, Nam-Ho Kim5, Shin-Wook Kang1 |
| 초록 |
Background: Cardiovascular (CV) disease is the main cause of death in patients with end-stage renal disease (ESRD). Even though hyperlipidemia is a well-established risk factor for CV mortality in the general population, the association between abnormal lipid levels and CV mortality in ESRD patients remains unclear. The aim of this study was to elucidate the impact of dyslipidemia on the clinical outcome in incident hemodialysis (HD) patients.
Methods: A prospective cohort of 867 incident HD patients from 36 centers of the Clinical Research Center for ESRD in Korea was selected for this study, and the relationship of various lipid levels with a composite of all-cause mortality and CV events (primary outcome) was clarified. Patients were stratified into tertile groups based on the baseline serum total, LDL-, and HDL-cholesterol, and triglyceride concentrations as follows: total cholesterol (C), <137, 137-171, >171mg/dL; LDL-C, <72, 72-99, >100 mg/dL; HDL-C, <34, 34-44 and >44 mg/dL, and triglyceride, <89, 89-136, >136 mg/dL, and the primary endpoint was compared among the groups of each lipid category.
Results: The mean levels of serum total, LDL-, and HDL-C, and triglyceride were 157.8±47.7, 89.8±38.1, 40.5±13.4, and 125.4±71.1 mg/dL, respectively. During a mean follow-up duration of 20.4 months, 49 patients (5.7%) died and 73 CV events (8.4%) occurred. In each tertile of total C concentrations, 33 (11.3%), 40 (14.1%), and 36 patients (12.3%), respectively, reached the composite outcome (p=0.730). The proportion of patients who met the primary outcome was lower in the second tertile of LDL-C levels compared to the first and third tertile groups, but the difference did not reach statistical significance (p=0.079). In addition, there were no differences in the hazard ratios for the primary endpoint among the tertiles of triglyceride (p=0.747) and HDL-C concentrations (p=0.115). After adjustment for demographic and clinical characteristics, and parameters related to inflammation and malnutrition, the risks for reaching the composite outcome were still comparable among the tertile groups of each lipid profile. Moreover, even when lipid levels were treated as continuous variables, the results remained unaltered.
Conclusions: Serum lipid concentrations at the commencement of dialysis are not associated with short-term all-cause mortality and CV events in incident HD patients. However, further long-term studies are needed to verify these findings.
|